Today's News | Note: News feeds may no longer be available for the articles on this page.

Deals Re-Energize Biotech Sector 4:24 AM 5/28/2009
Wall Street Journal - USA
Positive clinical trials and lucrative financing deals inject fresh energy into the biotechnology industry. Exelixis Inc is licensing two of its experimental cancer drugs to Sanofi-Aventis. ...

AstraZeneca is sued over asthma drug deal 6:53 AM 5/27/2009
Los Angeles Times - CA,USA
Verus Pharmaceuticals Inc seeks $280 million in compensatory damages and $1 billion in punitive damages from AstraZeneca alleging they backed out of an agreement to work on Pulmicort together. ...

Amgen pays $50 million for rights to heart drug 4:38 AM 5/27/2009
Los Angeles Times - CA,USA
Amgen Inc paid $50 million for the rights to develop and market experimental drug CK-1827452 being developed to reactivate the heart's beating during heart failure. ...

Some Acid-Reflux Drugs Are Linked to Pneumonia 3:33 AM 5/27/2009
New York Times - United States
Proton pump inhibitors suppress acid in the stomach and may lead to pneumonia through growth of bacteria in the upper gastrointestinal and respiratory tract or by reducing coughing. ...

Cougar's prostate drug sees 70 pct response in trials 3:07 PM 5/26/2009
Reuters - USA
Results of phase I/II trials have shown Cougar Biotechnology's prostate cancer drug abiraterone produced "significant benefits" in about two thirds of men on the drug. ...

Merck Gets High Court Hearing on Investor Vioxx Suit 12:31 PM 5/26/2009
Bloomberg - USA
The US Supreme Court agreed to consider Merck & Co’s bid to stop a shareholder lawsuit over the Vioxx painkiller arguing that the investors filed too late. ...

Sciele buys premature ejaculation drug candidate 12:21 PM 5/26/2009
Forbes - NY,USA
Sciele Pharma said it paid $8.4 million for the worldwide rights to premature ejaculation drug candidate PSD502 (lidocaine/prilocaine) developed by Plethora Solutions Holdings. ...

Novartis enters Japanese vaccines market 12:03 PM 5/26/2009
Reuters - USA
Novartis will enter the Japanese vaccines market through an agreement on Vaxem-Hib with local firm Takeda Pharmaceuticals. ...

FDA approves hyponatremia drug 9:30 AM 5/26/2009
United Press International - USA
The US FDA has approved Samsca tablets (tolvaptan) to treat hyponatremia. ...

Are generic drugs a bad bargain? 8:42 AM 5/26/2009
msnbc.com - USA
Generic drugs are getting less safe by the day unless you actually trust foreign manufacturers and the US FDA. ...

Map Pharma migraine drug hits all goals in study 7:47 AM 5/26/2009
Reuters - USA
MAP Pharmaceuticals Inc said its experimental orally inhaled migraine drug Levadex reached all four goals of a late-stage clinical study. ...

United Therapeutics gets FDA nod for oral PAH drug 6:38 AM 5/26/2009
Reuters - USA
United Therapeutics Corp said the US FDA approved its orally administered drug Adcirca (tadalafil) for the treatment of pulmonary arterial hypertension (PAH). Tadalafil is approved for the treatment of erectile dysfunction as Cialis. ...

FDA Okays Alternative To Botox But Agency Warns of Risks for Both ... 4:39 AM 5/26/2009
Washington Post - United States
The US FDA issued an order that Dysport and Botox must carry a warning that the material has the potential to spread from the injection site to distant parts of the body. ...

China says being demonised over fake drugs 4:02 AM 5/26/2009
Reuters - USA
Battling a string of tainted and counterfeit food and pharmaceutical cases Chinese officials have vowed to get tough. If that doesn't work, they'll vow to get even tougher. ...

Amgen Acquires Rights to New Heart Drug 2:29 AM 5/26/2009
New York Times - United States
Amgen paid $75 million to Cytokinetics for the option to drug CK-1827452. With more clinical trials data Amgen will assume control of further testing and marketing. ...

<- Day Earlier | Today's News